Preemptive and upfront plerixafor: Safe and effective strategy for patients undergoing autologous stem cell transplant and at high risk for mobilization failure

Preemptive and upfront plerixafor: Safe and effective strategy for patients undergoing autologous stem cell transplant and at high risk for mobilization failure

Introduction: Approximately 10%–30% of patients are unable to collect the minimum number of stem cells to support high-dose chemotherapy and autologous stem cell transplant (hematopoietic stem cell transplantation). Plerixafor alone or in combination with granulocyte colony-stimulating factor (G-CSF...

Full description

Saved in:
Bibliographic Details
Main Authors: Vipul Sheth, Reetu Jain, Adwaita Gore, Amit Ghanekar, Tapan Saikia
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
autologous stem cell transplant
plerixafor
preemptive upfront
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=1;spage=19;epage=22;aulast=Sheth
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items